Chromadex Corp (CDXC)

NASDAQ
Currency in USD
5.870
+0.290(+5.20%)
Closed
Pre Market
6.000+0.130(+2.21%)
CDXC Scorecard
Full Analysis
Net income is expected to grow this year
Earnings results expected in 15 days
Fair Value
Day's Range
5.6205.955
52 wk Range
1.4807.974
Key Statistics
Edit
Prev. Close
5.87
Open
5.65
Day's Range
5.62-5.955
52 wk Range
1.48-7.974
Volume
543.6K
Average Volume (3m)
530.5K
1-Year Change
262.35%
Book Value / Share
0.45
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CDXC Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
7.960
Upside
+35.60%
Members' Sentiments
Bearish
Bullish
ProTips
3 analysts have revised their earnings upwards for the upcoming period
Show more

Chromadex Corp Company Profile

ChromaDex Corporation operates as a bioscience company focusing on developing healthy aging products. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingredients directly to consumers and distributors; and develops and commercializes proprietary-based ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. The company also commercializes NAD+ precursor nicotinamide riboside as the flagship ingredient NIAGEN; NIAGEN as an active ingredient in its consumer products under the TRU NIAGEN name; and Immulina, a spirulina extract with predominant active compounds of Braun-type lipoproteins for supporting human immune function. In addition, it offers phytochemical reference standards, and other research and development services. The company distributes TRU NIAGEN products direct to consumers through its propriety e-commerce platform TRUNIAGEN.com, Amazon, ShopHQ, and other internet marketplaces, as well as specialty retailers and direct healthcare practitioners in the United States. ChromaDex Corporation was founded in 1999 and is headquartered in Los Angeles, California.

Compare CDXC to Peers and Sector

Metrics to compare
CDXC
Peers
Sector
Relationship
P/E Ratio
302.6x−8.3x−0.7x
PEG Ratio
2.490.010.00
Price/Book
13.1x2.3x2.6x
Price / LTM Sales
4.9x3.3x3.1x
Upside (Analyst Target)
36.3%36.4%47.6%
Fair Value Upside
Unlock12.0%7.7%Unlock

Analyst Ratings

5 Buy
0 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 7.960
(+35.60% Upside)

Earnings

Latest Release
Oct 31, 2024
EPS / Forecast
0.02 / 0.01
Revenue / Forecast
25.60M / 24.03M
EPS Revisions
Last 90 days

FAQ

What Is the Chromadex Corp (CDXC) Stock Price Today?

The Chromadex Corp stock price today is 5.87.

What Stock Exchange Does Chromadex Corp Trade On?

Chromadex Corp is listed and trades on the NASDAQ stock exchange.

What Is the Stock Symbol for Chromadex Corp?

The stock symbol for Chromadex Corp is "CDXC."

What Is the Chromadex Corp Market Cap?

As of today, Chromadex Corp market cap is 449.35M.

What is Chromadex Corp Earnings Per Share?

The Chromadex Corp EPS is 0.02.

What Is the Next Chromadex Corp Earnings Date?

Chromadex Corp will release its next earnings report on 04 Mar 2025.

From a Technical Analysis Perspective, Is CDXC a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.